文献速递脑血管病

基因决定的FXI(凝血因子XI)水平与卒中风险

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke.
PubMed 文献 · Stroke · 2018-01-01

本研究采用两样本孟德尔随机化分析,探讨基因决定的FXI水平对缺血性卒中、心肌梗死和脑出血风险的影响。结果显示,基因决定的高FXI水平与任何缺血性卒中风险存在因果关联(OR 2.54),其效应主要由心源性栓塞型(OR 4.23)和不明原因型(OR 3.44)驱动,但与心肌梗死和脑出血无显著关联。

要点

  • 基因决定的高FXI水平与任何缺血性卒中风险升高相关(OR 2.54,95%CI 1.68-3.84)。
  • FXI水平与心源性栓塞型卒中风险升高相关(OR 4.23,95%CI 1.94-9.19)。
  • FXI水平与心肌梗死和脑出血风险无显著关联。

核心结论

  • 孟德尔随机化证据支持FXI可能是降低心源性栓塞型缺血性卒中风险的潜在靶点。

研究设计与样本

  • 两样本孟德尔随机化分析。FXI水平的工具变量和遗传关联估计来自对16169名个体的全基因组关联研究。
  • 缺血性卒中及其病因亚型的遗传关联估计来自16851例病例和32473例对照的研究。
  • 心肌梗死的估计来自43676例病例和123504例对照的研究,脑出血的估计来自1545例病例和1481例对照的研究。

主要发现

  • 经Bonferroni多重检验校正后,孟德尔随机化分析支持基因决定的高FXI水平对任何缺血性卒中风险有因果效应(自然对数转换的FXI水平每增加1个单位,OR 2.54;95%CI 1.68-3.84;P=1×10-5)。
  • 基因决定的高FXI水平与心肌梗死无显著关联(OR 1.01;95%CI 0.76-1.34;P=0.94),与脑出血也无显著关联(OR 1.81;95%CI 0.44-7.38;P=0.41)。
  • 在缺血性卒中亚型中,主要结果支持基因决定的高FXI水平与心源性栓塞型卒中风险相关(OR 4.23;95%CI 1.94-9.19;P=3×10-4),与不明原因型缺血性卒中风险相关(OR 3.44;95%CI 1.79-6.60;P=2×10-4)。
  • 基因决定的高FXI水平与大动脉粥样硬化型卒中(OR 2.73;95%CI 1.15-6.45;P=0.02)和小动脉闭塞型卒中(OR 1.19;95%CI 0.50-2.82;P=0.69)无显著关联。
  • 不明原因型缺血性卒中的统计学显著结果在所有敏感性分析中未被重复。

局限性

  • 不明原因型缺血性卒中的统计学显著结果在所有敏感性分析中未被重复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- FXI (factor XI) is involved in thrombus propagation and stabilization. It is unknown whether lower FXI levels have a protective effect on risk of ischemic stroke (IS) or myocardial infarction. This study investigated the effect of genetically determined FXI levels on risk of IS, myocardial infarction, and intracerebral hemorrhage. Methods- Two-sample Mendelian randomization analysis was performed. Instruments and genetic association estimates for FXI levels were obtained from a genome-wide association study of 16 169 individuals. Genetic association estimates for IS and its etiological subtypes were obtained from a study of 16 851 cases and 32 473 controls. For myocardial infarction, estimates were obtained from a study of 43 676 cases and 123 504 controls and for intracerebral hemorrhage from a study of 1545 cases and 1481 controls. Results- After applying a Bonferroni correction for multiple testing, the Mendelian randomization analysis supported a causal effect of higher, genetically determined FXI levels on risk of any IS (odds ratio [OR] per 1-unit increase in natural logarithm-transformed FXI levels, 2.54; 95% CI, 1.68-3.84; P=1×10-5) but not myocardial infarction (OR, 1.01; 95% CI, 0.76-1.34; P=0.94) or intracerebral hemorrhage (OR, 1.81; 95% CI, 0.44-7.38; P=0.41). Examining IS subtypes, the main results supported an effect of higher, genetically determined FXI levels on risk of cardioembolism (OR, 4.23; 95% CI, 1.94-9.19; P=3×10-4) and IS of undetermined cause (OR, 3.44; 95% CI, 1.79-6.60; P=2×10-4) but not large artery atherosclerosis (OR, 2.73; 95% CI, 1.15-6.45; P=0.02) or small artery occlusion (OR, 1.19; 95% CI, 0.50-2.82; P=0.69). However, the statistically significant result for IS of undetermined cause was not replicated in all sensitivity analyses. Conclusions- We find Mendelian randomization evidence supporting FXI as a possible target to reduce risk of the cardioembolic subtype of IS.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gill D, Georgakis MK, Laffan M, et al. Genetically Determined FXI (Factor XI) Levels and Risk of Stroke. Stroke. 2018. PMID: 30355187. doi:10.1161/STROKEAHA.118.022792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。